Cancer control research in the North Central Cancer Treatment Group (NCCTG).
Loprinzi
C L
CL
Mayo Clinic, Rochester, MN 55905.
Miser
A W
AW
Kardinal
C
C
Everson
L K
LK
Ahlquist
D A
DA
Dose
A M
AM
Moertel
C G
CG
D000493:Allopurinol / Q000627:therapeutic use; D000855:Anorexia / Q000188:drug therapy / Q000209:etiology; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002100:Cachexia / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000175:diagnosis; D003533:Cyproheptadine / Q000627:therapeutic use; D003692:Delayed-Action Preparations / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D015146:Midwestern United States; D009020:Morphine / Q000627:therapeutic use; D009067:Mouthwashes / Q000627:therapeutic use; D009369:Neoplasms / Q000150:complications / Q000628:therapy*; D012106:Research; D013280:Stomatitis / Q000517:prevention & control
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D009067:Mouthwashes; D003533:Cyproheptadine; D000493:Allopurinol; D009020:Morphine; D005472:Fluorouracil